Product Description
Tirzepatide is a synthetic dual incretin peptide that acts as a GLP-1 and GIP receptor agonist, designed to optimize blood sugar regulation, appetite control, and metabolic health. By mimicking the natural hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), Tirzepatide enhances insulin secretion, suppresses glucagon, and slows gastric emptying, leading to improved glycemic control and significant weight loss outcomes.
Its unique structure includes a fatty acid side chain that extends its half-life, allowing for once-weekly subcutaneous dosing.